Notice Number: NOT-AG-18-032

Key Dates
Release Date:October 9, 2018

Issued by
National Institute on Aging (NIA)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute on Aging (NIA) will participate, effective immediately, in the Funding Opportunity Announcement (FOA) PA-18-917, "Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional)".

The following sections have been updated to reflect the participation of NIA in this Funding Opportunity Announcement.

Part 1. Overview Information

The following information has been added:

Components of Participating Organizations:
National Institute on Aging (NIA)

Catalog of Federal Domestic Assistance (CFDA) Number(s):
93.866

Part 2. Section I. Funding Opportunity Description

Objectives:

The following information has been added:
NIA: Research on the mechanisms by which endocannabinoids influence the pain processing in older adults with pain conditions or relevant aging animal models; the therapeutic effects, pharmacodynamics, or side effects of endocannabinoids in the aged; the interaction of endocannabinoids with other commonly used medications in older adults; and research comparing the effectiveness of endocannabinoids with that of other pain treatments for older adults.

Part 2. Section VII. Agency Contacts

The following contacts have been added:

Scientific/Research Contact(s):
Coryse St. Hillaire-Clarke, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-827-6944
Email: [email protected]

Financial/Grants Management Contact(s):
Jeff Ball
National Institute on Aging (NIA)
Telephone: 301-402-7732
Email: [email protected]

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Coryse St. Hillaire-Clarke, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-827-6944
Email: [email protected]